Presentations from meetings

A list of reports, briefings and presentations from UK CAB meetings.

This includes PowerPoints and PDFs hosted on this website and selected additional materials hosted on eternal websites. All of these have been presented or discussed at UK CAB meetings.

Estimating loss to follow up among persons accessing HIV care in England, Wales and Northern Ireland

Brian Rice, Valerie Delpech, Alison Brown and Zheng Yin, 04/13/2012  [PDF, 512 Kb]

HIV Drug Resistance

David Dunn, 04/13/2012  [PDF, 6.3Mb]

Less frequent tests, what impact on HIV care?

Dr Nashaba Matin, 04/13/2012  [PDF, 1Mb]

Patient reporting of medicines-related problems

Paul Clift, 04/13/2012  [PDF, 100Kb]

HIV Activism at 30

Robert James, 04/13/2012  [PDF, 512Kb]

Patient information security

Nathan Lea, 04/13/2012  [PDF, 1.1Mb]

Company meeting with Janssen

Dr Michael Aboud, Medical Lead Virology, 01/20/2012  [PowerPoint, 6 Mb]

Strengething community response to TB-HIV

Gitau Mburu, 01/20/2012  [PDF, 1.2Mb]

TB and HIV treatment and screening

Dr Santino Capocci, 01/20/2012  [PDF, 3.9Mb]

The XX Factor – women and HIV

Dr Jane Anderson, Homerton University Hospital, 10/21/2011  [PDF, 1.1Mb]

HIV research and gender

Lucy Campbell, King's College, London, 10/21/2011  [PDF, 316Kb]

Gender and HIV research: history and overview

Angelina Namiba, HIV i-Base, 10/21/2011  [PDF, 56Kb]

HIV and brain function

Dr Tristan Barber, 2011  [PDF, 464KB]

HIV, antiretroviral therapy and the brain

Dr Sam Nightingale, 2011  [PDF, 7.7MB]

London drug commissioning 2011

, 2011  [PDF, 68KB]

iPrEX Trial Design: statistical aspect of the results relating to the adherence data

Dr Colette Smith, 2011  [PDF, 120Kb]

Genital Tract ART Implications for transmission 2010

Dr Steve Taylor, 2011  [PowerPoint, 6MB]

CROI 2010 feedback

Simon Collins, 2010  [PDF, 172 Kb]

Poster: Africans in UK present late and are likely to be on ARVs soon after an HIV diagnosis

Dr Getrude Wafula-Anyango, 2010  [PDF, 2.2 MB]

HIV and MSM in England: A new wave of challenge

Adebisi Alimi, 2010  [PowerPoint, 452 Kb]

African sub-groups session Issues for Men

Jabulani Chwaula, 2010  [PowerPoint, 1.2 MB]

African Treatment Issues and HPA data on late diagnosis

Dr Ade Fakoya, 2010  [PDF, 1.2 MB]

Feedback from BHIVA Conference

Robert James, 2009  [PDF, 56 Kb]

Ageing with HIV: Project overview Frontline HIV Forum

John J.J. O’Callaghan-Williamson, 2009  [PowerPoint, 2.1 MB]

Proposed Ageing Study

Caroline Sabin, 2009  [PowerPoint, 720 Kb]

IAS Feedback Cape Town 2009

Simon Collins, 2009  [PDF, 3.2 Mb]

BMS Data Update

Dr Keith Aizen, Victoria Adamson BMS, 2009  [PowerPoint, 3.3 Mb]

Additional files:

Advocacy Training in Practice

Winnie Sseruma, 2009  [PowerPoint, 564 Kb]

Additional files:

HIV Treatment Advocacy Overview

Michael Marr, 2009  [PowerPoint, 948 Kb]

Additional files:

Draft BHIVA Guidelines Routine Monitoring of HIV

Matthew Williams, 2009  [PowerPoint, 948 Kb]

Additional files:

BHIVA feedback

Simon Collins, 2009  [PowerPoint, 844 Kb]

Additional files:

Feedback from CROI – BHIVA

Simon Collins, 2009  [PDF, 72 Kb]

HIV and Drug Resistance

Simon Collins, 2009  [PDF, 2.2 Mb]

Introducing the HIV Vaccine Advisory Board

Ken Legg, 2009  [PowerPoint, 556 Kb]

Additional files:

When to Start Therapy? The Patient’s Viewpoint

Gus Cairns, 2009  [PowerPoint, 1.6 Mb]

A rough guide to the immune system

Dr Adrian Palfreeman, 2009  [PowerPoint, 1.1 Mb]

Intelence (Etravirine) Update

Rekha Sinha, MD, 2009  [PowerPoint, 1.7Mb]

TMC278 Update

Peter Williams, 2009  [PowerPoint, 888 Kb]

TMC207 Update

Karel de Beule, 2009  [PowerPoint, 364 Kb]

Etravirine, Darunavir and pipeline HIV plus HCV and TB

Tibotec, 2009  [PowerPoint, 876 Kb]

Overview

Tibotec, 2009  [PowerPoint, 3.1 Mb]

Mexico feedback: research overview

Simon Collins, HIV i-Base, 2008  [PDF, 1.2 Mb]

Mexico feedback: social issues

Paul Clift, UK-CAB, 2008  [PDF, 1 Mb]

Additional files:

BHIVA/CHIVA feedback

Matt Williams, UK-CAB, 2008  [PowerPoint, 369 Kb]

Additional files:

Young people and HIV: a social support perspective

Maria Phelan, NCB, Oct 2008  [PDF, 256 Kb]

Additional files:

Undetectable = uninfectious? Treatment as prevention

Dr Bernard Hirschel, University Hospital, Geneva, 2008  [PDF, 232 Kb]

Undetectable = uninfectious? Community response

Edwin J Bernard, NAM, 2008  [PowerPoint, 375 Kb]

Undetectable = uninfectious? Community response

Silvia Petretti, Positively Women/PozFem UK, 2008  [PowerPoint, 245 Kb]

Guidance for public on reporting side effects

Guidance for public on reporting side effects

(link to external site) MRHA, 2008  [PDF, 65 Kb]

10 essential actions for effective TB infection control

10 essential actions for effective TB infection control

(link to external site) Stop TB Partnership, 2008  [PDF, 231 Kb]

Describing the risk of an event and identifying risk factors

Dr Caroline Sabin, Royal Free Hospital, 2008  [PowerPoint, 336 Kb]

CROI 2008 feedback: understanding statistics in 3 studies

Simon Collins, HIV i-Base, 2008  [PDF, 4 Mb]

D:A:D position statement – abacavir, ddI and risk of heart attack

D:A:D position statement

(link to external site) D:A:D steering committee, 2008  [PDF, 63 Kb]

Immigration removal centres and HIV

Joe Murry, Policy Officer, NAT, 2007  [PowerPoint, 214 Kb]

Tests and monitoring in HIV infection

Matt Williams, UK CAB, 2007  [PowerPoint, 558 Kb]

Viral tropism

Matt Williams, UK CAB, 2007  [PDF, 592 Kb]

Monitoring HIV infection and treatment in the era of HAART

Dr Simon Edwards, Mortimer Market Centre, 2007  [PowerPoint, 152 Kb]

Sisters are doing it for themselves: women, sexual health and HIV

(link to external site) HIV Scotland, 2007  [PDF, 1.5 Mb]

BHIVA Audit 2006-7: survey of patient assessment and monitoring

BHIVA Audit 2006-7: survey of patient assessment and monitoring

(link to external site) BHIVA, 2007  [PDF, 80 Kb]

Women, HIV and microbicides seminar report

Women, HIV and microbicides seminar report

(link to external site) George House Trust and UK African Microbicides Working Group, 2007  [PDF, 210 Kb]

BHIVA standards project

Hilary Curtis, 2006  [PowerPoint, 258 Kb]

Human rights protection for people with HIV/AIDS

Human rights protection for people with HIV/AIDS

(link to external site) Hermione McEwen, Senior Solicitor, Greater Manchester Immigration Aid Unit, 2006  [PowerPoint, 42 Kb]

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

(link to external site) Department of Health, 2008  [PDF, 493 Kb]

Update on the neurological manifestations of HIV

Justin McArthur, MBBS, MPH, Professor of Neurology and Epidemiology, Johns Hopkins University School of Medicine (PRN Notebook), 2005  [PDF, 192 Kb]

CAB steering group feedback

Mark McPherson, UK CAB, 2005  [PowerPoint, 164 Kb]

HIV Clinical trials at MRC Clinical Trials Unit

Nick Paton, MRC Clinical Trials Unit, 2005  [PowerPoint, 1.3 Mb]

Entry inhibitors and immunology

Simon Collins, HIV i-Base, 2005  [PowerPoint, 116 Kb]

Paediatric HIV care

HIV i-Base, 2005  [PowerPoint, 547 Kb]

BHIVA treatment guidelines 2005

Simon Collins, HIV i-Base, 2005  [PowerPoint, 84 Kb]

BHIVA guidelines: what’s new – new drugs

Brian West, HIV Scotland, 2005  [PDF, 620 Kb]

Participating in an HIV vaccine trial

Jo Robinson, EATG Vaccines Working Group, 2004  [PowerPoint, 212 Kb]

HIV vaccine clinical trials: the need for community involvement

Ken Legg, Imperial College of London, 2004  [PowerPoint, 448 Kb]

Community participation in western Europe

Emmanuel Trénado, EATG Vaccines Working Group, 2004  [PowerPoint, 2.1 Mb]

Community participation in eastern Europe

Dmitry Samoylov, Community of People Living with HIV/AIDS, Moscow, 2004  [PDF, 1.4 Mb]

European AIDS vaccine trials: an advocacy agenda

Marion Zibelli, EATG Vaccine Working Group, 2004  [PowerPoint, 148 Kb]

Statistics part 3: design of randomised controlled trials of treatments for HIV infection

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2004  [PowerPoint, 312 Kb]

Introduction to basic vaccine technology

Henry Graeme-Smith, 2004  [PowerPoint, 416 Kb]

Topical microbicides

Jo Robinson, THT in cooperation with the Global Campaign for Microbicides, 2004  [PowerPoint, 3.4 Mb]

International AIDS Vaccine Initiative

Maite Suarez, IAVA, 2004  [PowerPoint, 1.9 Mb]

Community involvement in vaccine and microbicide research

Julian Meldrum, 2004  [PowerPoint, 48 Kb]

Thorny issues in HIV vaccine trials

Saul Walker, Policy Advisor. IAVI, 2004  [PowerPoint, 272 Kb]

Towards error-free HIV diagnosis: guidelines on laboratory practice

Towards error-free HIV diagnosis: guidelines on laboratory practice

(link to external site) JV Parry, PP Mortimer, KR Perry, D Pillay, M Zuckerman, for the Health Protection Agency HIV Laboratory Diagnosis Message board (Communicable Disease and Public Health), December 2003  [PDF, 332 Kb]

Statistics part 2: hypothesis (significance) testing – more complex statistical methods

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003  [PDF, 464 Kb]

Statistics part 1: different types of study design – describing and displaying data

Dr Caroline Sabin, Reader in Medical Statistics and Epidemiology, Department of Primary Care and Population Sciences, 2003  [PDF, 628 Kb]

Enfuvirtide (T-20)

Roche, Leroy Benons, Medical Advisor – HIV, Roche, 2003  [PowerPoint, 5 Mb]

Access to HIV treatment: issues of working with HIV positive refugees and asylum seekers

Linda McDonald MA MSc RN, 2003  [PowerPoint, 61 Kb]

TB and HIV

Dr Anton Pozniak, Chelsea and Westminster Hospital, 2003  [PowerPoint, 880 Kb]

Hepatits C/HIV coinfection

Dr Ranjababu Kulasegaram, Guy’s and St Thomas’ Hospital, 2003  [PDF, 748 Kb]

Additional files:

Principles of care of the HIV-1 infected pregnant mother

Principles of care of the HIV-1 infected pregnant mother

(link to external site) Dr Karen Beckerman, Assistant Professor of Obstetrics and Gynaecology, New York University, October 2002  [PDF, 5.1 Mb]

HIV and subfertility

Leila Frodsham, Clinical Research Fellow, Assisted Conception Unit, Chelsea and Westminster, 2002  [PowerPoint, 338 Kb]

Tipranavir: design of the RESIST study

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 468 Kb]

Unique resistance profile of tipranavir

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 696 Kb]

Clinical aspects of treatment with tipranavir

Dr Kevin Curry, Boehringer Ingelheim, 2002  [PowerPoint, 444 Kb]

Understanding HIV-1 drug resistance testing

Professor Clive Loveday, International Clinical Virology Centre, 2002  [PDF, 2.5 Mb]

Salvage therapy

Dr Mike Youle, Royal Free Centre for HIV Medicine, 2002  [PDF, 1.1 Mb]

Methods of drug evaluation

Tim Peto, MRC Clinical Trials Unit, 2002  [PowerPoint, 332 Kb]

Additional files:

Gilead: tenofovir

Gilead Sciences, 2002  [PDF, 328 Kb]

Additional files:

Atazanavir

BMS, 2002  [PowerPoint, 834 Kb]

Informed consent and patient involvement in trials

Norbert Tamm, Research Charge Nurse, Imperial College and St Mary’s Hospital, 2002  [PowerPoint, 52 Kb]

Additional files:

d4T (stavudine, Zerit) extended release

BMS, 2002  [PowerPoint, 166 Kb]

DPC 083-201 (DuPont 083)

Dr Nancy Ruiz, 2002  [PowerPoint, 914 Kb]